Economic Impact of Atrial Fibrillation on Hospitalization Outcomes of Acute Heart Failure in the United States
Section snippets
Disclosures
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References (7)
- et al.
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Lancet Lond Engl
(2015) - et al.
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States
Value Health J Int Soc Pharmacoeconomics Outcomes Res
(2006) - et al.
Epidemiology and economic burden of atrial fibrillation
J Epidemiol Econ Burd Atr Fibrillation
(2020)
There are more references available in the full text version of this article.
Cited by (1)
Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
2023, Journal of Comparative Effectiveness Research
© 2020 Elsevier Inc. All rights reserved.